[1]梁 姣,袁 雯,王晓娟.紫草油联合化瘀生肌方对老年压力性损伤患者创面愈合时间及血管内皮生长因子表达的影响[J].陕西中医,2023,(12):1722-1725.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.012]
　LIANG Jiao,YUAN Wen,WANG Xiaojuan.Effects of comfrey oil combined with Huayu Shengji formula on wound healing time and expression of VEGF in aged patients with iatrogenic stress injury[J].,2023,(12):1722-1725.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.012]
点击复制

紫草油联合化瘀生肌方对老年压力性损伤患者创面愈合时间及血管内皮生长因子表达的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年12期
页码:
1722-1725
栏目:
临床研究
出版日期:
2023-12-05

文章信息/Info

Title:
Effects of comfrey oil combined with Huayu Shengji formula on wound healing time and expression of VEGF in aged patients with iatrogenic stress injury
作者:
梁 姣; 袁 雯; 王晓娟
(新疆医科大学附属中医医院,新疆 乌鲁木齐 830054)
Author(s):
LIANG Jiao; YUAN Wen; WANG Xiaojuan
(Xinjiang Medical University Affiliated Traditional Chinese Medicine Hospital,Urumqi 830054,China)
关键词:
压力性损伤;  紫草油;  化瘀生肌方;  炎性因子;  血管内皮生长因子;  压疮愈合程度;  中医症候积分
Keywords:
Stress injury;  Comfrey oil;  Huayu Shengji formula;  Inflammatory factors;  VEGF;  Pressure ulcer healing degree;  TCM syndrome score
分类号:
R 751
DOI:
DOI:10.3969/j.issn.1000-7369.2023.12.012
文献标志码:
A
摘要:
目的:分析紫草油联合化瘀生肌方对3～4期老年压力性损伤创面愈合时间、炎性因子、血管内皮生长因子(VEGF)表达的影响。方法:选取3～4期老年压力性损伤患者92例纳入研究,随机分为对照组(化瘀生肌方治疗)、观察组(紫草油联合化瘀生肌方治疗),每组46例。观察两组治疗前、治疗2个月的中医症候积分、压疮愈合程度评分及VEGF、炎性因子水平。统计两组临床疗效、肉芽组织出现时间、创面愈合时间以及不良反应。结果:与对照组治疗后相比,观察组治疗总有效率较高(P<0.05)。与对照组比较,观察组中医症候积分与压疮愈合程度评分较低(均P<0.05)。与对照组比较,观察组肉芽组织出现时间、创面愈合时间较短(均P<0.05)。治疗后,观察组创面组织表皮生长因子(EGF)、碱性成纤维细胞生长因子(bFGF)、血管内皮生长因子(VEGF)水平高于对照组,炎性因子肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)、C反应蛋白(CRP)水平低于对照组(均P<0.05)。两组不良反应发生率比较差异无统计学意义(P>0.05)。结论:紫草油与化瘀生肌方联合治疗不仅可以有效改善3～4期老年压力性损伤患者中医症候积分与压疮愈合程度评分,还能降低机体炎症因子水平,提高VEGF表达,缩短创面愈合时间。
Abstract:
Objective:To analyze the effects of comfrey oil combined with Huayu Shengji formula on wound healing time,expression of inflammatory factors and VEGF in aged patients with iatrogenic stress injury in stage 3 to 4.Methods:A total of 92 elderly patients with stage 3 to 4 pressure injury were included in the study,they were randomly divided into control group(Huayu Shengji formula treatment)and observation group(comfrey oil combined with Huayu Shengji formula treatment),with 46 cases in each group.TCM syndrome score,pressure sore healing degree score,VEGF and inflammatory factor levels were observed before treatment and two months after treatment.The clinical efficacy,granulation time,wound healing time and adverse reactions of the two groups were analyzed.Results:Compared with the control group,the total effective rate of the observation group was higher(P<0.05).Compared with control group,TCM syndrome score and pressure sore healing degree score of observation group were lower(P<0.05).Compared with the control group,the granulation formation time and wound healing time of observation group were shorter(all P<0.05).After treatment,the levels of EGF,bFGF and VEGF in observation group were higher than those in control group,and the levels of inflammatory factors TNF-α,IL-6 and CRP were lower than those in control group(all P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:The combined treatment of comfrey oil and Huayu Shengji formula can not only effectively improve the TCM syndrome score and pressure sore healing degree score of elderly patients with pressure injury in stage 3 to 4,but also reduce the level of inflammatory factors,increase the expression of VEGF,and shorten the time of wound healing.

参考文献/References:

[1] 兰正燕,李开琲,康 静,等.老年脊髓损伤患者压力性损伤发生现况及影响因素分析[J].老年医学与保健,2021,27(3):577-580.
[2] 郭 璐,赵兵刚,冯 婷,等.生肌散抑制RIP1/RIP3/MLKL通路介导大鼠压疮形成实验研究[J].陕西中医,2021,42(11):1517-1521.
[3] 孙晓丽,王华丽,青 华.老年晚期胃癌患者发生医院获得性压疮现状及危险因素调查研究[J].陕西医学杂志,2020,49(8):1049-1052.
[4] Gay CM,Parseghian CM,Byers LA.This is our cells under pressure:Decreased DNA damage repair in response to targeted therapies facilitates the emergence of drug-resistant clones[J].Cancer Cell,2020,37(1):5-7.
[5] 李景宇,王梅青,宿 佳,等.益气活血生肌方对高位复杂性肛瘘术后创面愈合的临床观察[J].中国临床医生杂志,2020,48(8):1003-1005.
[6] 张 坤,彭金霞,任 琳.化瘀生肌方提取物对糖尿病溃疡模型大鼠创面愈合的影响[J].解放军药学学报,2018,34(4):313-316.
[7] 左 楠,崔 莉,王 爽.脂肪间充质干细胞对小鼠创面组织超氧化物歧化酶及血管内皮生长因子、表皮生长因子、碱性成纤维细胞生长因子表达的影响[J].陕西医学杂志,2022,51(1):7-10,24.
[8] 吴 健,周美英,史旭锋,等.雌激素联合复方紫草油治疗对糖尿病大鼠烫伤创面愈合的影响[J].世界中医药,2018,13(5):1218-1221.
[9] 褚万立,郝岱峰.美国国家压疮咨询委员会2016年压力性损伤的定义和分期解读[J].中华损伤与修复杂志:电子版,2018,13(1):64-68.
[10] 戴 慎,薛建国.中医病证诊疗标准与方剂选用[M].北京:人民卫生出版社,2001:1032.
[11] 雷作熹,向日晖,何进财,等.老年压疮住院患者临床特点及中医证候分析[J].中医临床研究,2020,12(36):140-142.
[12] 李佩芳,宁 宁,陈佳丽,等.Bates-Jensen伤口评估与效果评价量表在治疗慢性伤口中的应用[J].华西医学,2015,30(10):1835-1837.
[13] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:128.
[14] 孙崇秋,崔秀华,武庆梅,等.四妙汤加减联合湿性敷料治疗4期压力性损伤疗效观察[J].湖北中医药大学学报,2022,24(4):85-87.
[15] 程 红,马希佳,任 娟,等.芪归紫草油干预大鼠Ⅳ期压力性损伤的实验研究[J].中国中医基础医学杂志,2022,28(2):210-212.
[16] 迮 侃,李 欣,李福伦,等.祛瘀生肌方对大鼠糖尿病皮肤溃疡创面愈合和组织中PGT、PGE2和VEGF含量的影响[J].辽宁中医杂志,2019,46(4):860-862,900.
[17] 卢 怡,丁晓杰,祁 菲,等.祛瘀生肌方含药血清对人真皮微血管内皮细胞迁移和PGT相关因子的影响[J].中国中西医结合杂志,2020,40(9):1088-1093.
[18] 龙 庆,李 俊,闻 永,等.康复新液联合紫草油纱条在肛裂术后换药中的应用研究[J].世界中西医结合杂志,2018,13(5):703-705,709.
[19] 张历元,李元文,林欢儿,等.复方紫草油联合氯雷他定治疗轻、中度特应性皮炎的临床观察[J].世界中医药,2019,14(6):1511-1515.
[20] 裴秋艳,王 平,李志刚,等.表皮生长因子联合银离子敷料对Ⅲ期、Ⅳ期压力性损伤患者血清炎性细胞因子和临床疗效的影响[J].四川医学,2022,43(1):63-66.
[21] 刘海艳,张春玲,赵 伟,等.基于PINK1/Parkin信号通路探讨丹黄散在糖尿病小鼠溃疡创面愈合中的作用[J].陕西中医,2023,44(4):433-436.
[22] 汤典慧,许 敏,雷群芳,等.复方紫草油微乳的药效学考察[J].中南药学,2018,16(7):954-957.
[23] 马文礼,马小娟,马娟弟,等.紫草油对激素依赖性皮炎豚鼠模型的影响及机制[J].中国皮肤性病学杂志,2023,37(1):35-41.
[24] Fisher SA,Tam RY,Fokina A,et al.Photo-immobilized EGF chemical gradients differentially impact breast cancer cell invasion and drug response in defined 3D hydrogels[J].Biomaterials,2018,19(178):751-766.
[25] Wu Z,Zhou Y,Chen L,et al.Binding efficiency of recombinant collagen-binding basic fibroblast growth factors(CBD-bFGFs)and their promotion for NIH-3T3 cell proliferation[J].Biopolymers,2018,109(3):93-105.
[26] Longchamp A,Mirabella T,Arduini A,et al.Amino acid restriction triggers angiogenesis via GCN2/ATF4 regulation of VEGF and H2S production[J].Cell,2018,173(1):117-129.

备注/Memo

备注/Memo:
基金项目:新疆维吾尔自治区重点研发计划项目(2021B03006); 新疆医科大学附属中医医院课题(ZYY201924)
更新日期/Last Update: 2023-12-08